2021GXNSFDA075014/Natural Science Foundation of Guangxi Province[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.

Zhao L, Kang M, Liu X, Wang Z, Wang Y, Chen H, Liu W, Liu S, Li B, Li C, Chang A, Tang B. Zhao L, et al. J Exp Clin Cancer Res. 2022 Nov 24;41(1):330. doi: 10.1186/s13046-022-02528-6. J Exp Clin Cancer Res. 2022. PMID: 36419136 Free PMC article.

LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.

Wang H, Wang Y, Lai S, Zhao L, Liu W, Liu S, Chen H, Wang J, Du G, Tang B. Wang H, et al. Cell Death Discov. 2022 Nov 7;8(1):449. doi: 10.1038/s41420-022-01234-8. Cell Death Discov. 2022. PMID: 36344496 Free PMC article.

mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A.

Zhao L, Su H, Liu X, Wang H, Feng Y, Wang Y, Chen H, Dai L, Lai S, Xu S, Li C, Hao J, Tang B. Zhao L, et al. Cell Biosci. 2022 Nov 12;12(1):183. doi: 10.1186/s13578-022-00919-y. Cell Biosci. 2022. PMID: 36371321 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters